Effectiveness of Urinary Kidney Injury Molecule-1 to diagnose Subclinical Acute Kidney Injury induced by Extracorporeal Shock Wave Lithotripsy
DOI:
https://doi.org/10.51273/esc24.251320223Keywords:
Kidney injury molecule-1, KIM-1, extracorporeal shock wave lithotripsy, nephrolithiasis, serum creatinineAbstract
Objective: To find the effectiveness of Kidney Injury Molecule-1 (KIM-1) as biomarker in diagnosing Extracor-
poreal Shock Wave Lithotripsy (ESWL) induced renal damage by taking serum creatinine concentration as
gold standard
Materials and Method: In this interventional study, a total of (80) diagnosed patients of nephrolithiasis
undergoing ESWL of age ≥ (18) years were enrolled from the Outpatient Department of Mayo Hospital, Lahore.
After informed consent, urine and whole blood samples were drawn pre and post ESWL. Samples after centri-
fugation were analyzed for urinary KIM-1 levels employing sandwich ELISA technique. While serum creatinine
levels were measured by colorimetric photometry in the Advanced Research Lab of Biomedical Sciences,
King Edward Medical University, Lahore.
Results: Of (80) patients, 53 (66.3%) of them were males and 27 (33.8%) were femaless. Serum creatinine
levels were decreased by 0.15 times from the baseline after procedure of ESWL but remained within normal
clinical range. Whereas urinary KIM-1 levels were raised 2.04 times than the baseline after ESWL (p< 0.001)
depicting subclinical acute kidney injury. At a cut off value of >50.9pg/ml, urinary KIM-1 had a 71.25%
sensitivity and 46.25% specificity with AUC of 0.699 (p<0.001) to predict acute kidney injury after ESWL. A
strong positive correlation (r= 0.62, p<0.001) was found between pre and post ESWL values of KIM-1.
Conclusion: The noninvasive biomarker KIM-1 was observed more effective in our study for diagnosing ESWL–induced subclinical acute kidney injury than serum creatinine.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Esculapio Journal of SIMS
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.